J. R. W.

Allelic imbalance and biochemical outcome after radical prostatectomy (2006)

S.R.J., J.R.W., ...

Objective: To compare the incidence of allelic imbalance ( AI) in men with rapid disease progression with those who remained disease free after radical prostatectomy, with the aim of identifying...

Rho family GTPases are activated during HGF-stimulated prostate cancer-cell scattering (2005)

J.R.W., ...

Tumour markers for managing men who present with metastatic prostate cancer and serum prostate-specific antigen levels of < 10 ng/mL (2005)

J.R.W., ...

Cancer associated plexinB1 mutations (2003)

J.R.W.

Can little p53 staining be used to identify patients with aggressive superficial bladder cancer? (2003)

J.R.W., ...

Clinical features of patients who present with metastatic prostate carcinoma and serum prostate-specific antigen (PSA) levels (2003)

J.R.W., ...

Curing metastatic cancer: lessons from testicular germ-cell tumours (2003)

J.R.W.

False cell lines: the problem and a solution (2003)

J.R.W.

Neuroendrocrine differentiation in prostate cancer: is it detectable and treatable? (2003)

...

Prostate cancer (2003)

J.R.W.

Prostate epithelial stem cell isolation and culture (2003)

J.R.W.

Proteomics in the analysis of prostate cancer (2003)

...

Rapid identification of antisense mRNA-expressing clones using strand-specific RT-PCR (2003)

J.R.W.

Stability of the nucleotide excision repair proteins ERCC1 and XPA (2003)

J.R.W.

Stem cells and differentiation in human prostate cancer (2003)

J.R.W., ...

The comparative values of bone marrow aspirate and trephine for obtaining bone scan-targeted metastases from hormone-refractory prostate cancer (2002)

R.S.D., ...

Amplification of the androgen receptor gene in bone metastases from hormone-refractory prostate cancer (2002)

R.S.D., ...

The aim of this study was to examine the prevalence of androgen receptor (AR) amplification in metastases to bone and other sites in patients with hormone-refractory prostate cancer (HRPC) and to...

The comparative values of bone marrow aspirate and trephine for obtaining bone scan-targeted metastases from hormone-refractory prostate cancer (2002)

R.S.D., ...

The comparative values of bone marrow aspirate and trephine for obtaining bone scan-targeted metastases from hormone-refractory prostate cancer (2002)

R.S.D., ...

Samples of metastatic prostate cancer to bone are difficult to obtain. The aim of this study was to compare the results of bone marrow aspirate and trephine biopsy for obtaining metastatic...

Amplification of the androgen receptor gene in bone metastases from hormone-refractory prostate cancer (2002)

...

Hela cells 50 years on: the good, the bad and the ugly (2002)

J.R.W.

Mechanism of different sensitivity to cisplatin in nasopharyngeal carcinoma celss (2001)

J.R.W., ...

Epithelial cell differentiation pathways in the human prostate: Identification of intermediate phenotypes by keratin expression (2001)

...

Short tandem repeat profiling provides an international reference standard for human cell lines. (2001)

J.R.W., ...

All about prostate cancer (2001)

J.R.W.

Epithelial diferentiation pathways in the human prostate: (2001)

...

Methods to improve the efficacy of intravesical mitomycin C: results of a randomized phase III trial (2001)

J.R.W.

Over expression of semaphorin 3E in prostate cancer (2001)

J.R.W.

Predictive value of molecular genetic markers in superficial bladder cancer (2001)

...

STR profiling provides an international reference standard for human cell lines (2001)

J.R.W., ...

The immortalized urotsa cell line as a potential cell culture model of human urothelium (2001)

J.R.W., ...

The immortalized UROtsa cell line as a potential cell culture model of human urothelium (2001)

J.R.W., ...

Functional and immunocytochemical characterisation of human prostate stromal cells (2000)

...

Comparison of marker protein expression in benign prostatic hyperplasia in vivo and in vitro (2000)

...

Proliferative heterogeneity in the human prostate: Evidence for epithelial stem cells (2000)

...

Cell contamination leads to inaccurate data: we must take action now (2000)

J.R.W, ...

Defective repair of cisplatin-induced DNA damage caused by reduced XPA protein in testicular germ cell tumours (1999)

J.R.W., ...

Metastatic cancer in adults usually has a fatal outcome. In contrast, advanced testicular germ cell tumours are cured in over 80% of patients using cisplatin based combination chemotherapy [1]. An...

In vitro assessment of a collagen sponge for engineering urothelial grafts (1998)

J.R.W., ...

KW-2149 (7-N-[2-[gamma-L-glutamylamino]ethyldithio-ethyl] mitomycin C): DNA interactions and drug uptake following serum activation (1998)

...

7-N-[2-[gamma-L-glutamylamino]ethyldithio-ethyl] mitomycin C (KW-2149) is a mitomycin-C analogue currently being evaluated in clinical trials. It has been shown that KW-2149 is unusual in that it is...

KW-2149 (7-N-[2-[gamma-L-glutamylamino]ethyldithio-ethyl] mitomycin C): DNA interactions and drug uptake following serum activation (1998)

...

7-N-[2-[gamma-L-glutamylamino]ethyldithio-ethyl] mitomycin C (KW-2149) is a mitomycin-C analogue currently being evaluated in clinical trials. It has been shown that KW-2149 is unusual in that it is...

Reduced Capacity for initial stages of nuceotide excision repair in two testis tumour cell lines (1998)

J.R.W., ...

DNA repair capacity and cisplatin sensitivity of human testis tumour cells (1997)

...

Complementation analysis of testis tumour cells (1997)

J.R.W.

KW-2149 (7-N-[2-[gamma-L glutamylamino]ethyldithioethyl]mitomycin C): a new mitomycin-C activated by serum (1997)

J.R.W., ...

Identification of the Tuberous Sclerosis gene TSC1 on chromosome 9q34 (1997)

Van Slegtenhorst, De Hoogt, ...

Deference to Old Age

J. R. W.